Cambridge, United Kingdom

Joanna L Brookfield

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Cancer Research Technology Limited. Active years: 2021-2023.


% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joanna L Brookfield: Innovator in Cancer Research

Introduction

Joanna L Brookfield is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of cancer research through her innovative work. With a total of 2 patents, her inventions focus on developing new therapeutic options for proliferative disorders.

Latest Patents

Joanna's latest patents include the development of pyrimidinone derivatives as CDC7 inhibitors. These compounds are designed to inhibit the activity of the cell division cycle 7 (Cdc7) kinase enzyme. The invention also encompasses pharmaceutical compositions that utilize these compounds for the treatment of various proliferative disorders, including cancer. The potential applications of her work extend to other diseases or conditions where Cdc7 kinase activity plays a critical role.

Career Highlights

Joanna is currently associated with Cancer Research Technology Limited, where she continues to advance her research and innovations. Her work is pivotal in the ongoing fight against cancer, contributing to the development of new treatment strategies.

Collaborations

Joanna collaborates with notable colleagues, including Chukuemeka Tennyson Ekwuru and Katherine M Fowler. These partnerships enhance the scope and impact of her research efforts.

Conclusion

Joanna L Brookfield exemplifies the spirit of innovation in cancer research, with her patents paving the way for new therapeutic approaches. Her contributions are vital in the quest for effective treatments for cancer and other related diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…